Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-072491
Filing Date
2020-06-11
Accepted
2020-06-11 17:23:16
Documents
3
Effectiveness Date
2020-06-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2022378d1_defa14a.htm DEFA14A 25816
2 GRAPHIC tm2022378d1_defa14aimg01.jpg GRAPHIC 2592
3 GRAPHIC tm2022378d1_defa14aimg02.jpg GRAPHIC 2592
  Complete submission text file 0001104659-20-072491.txt   34401
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37990 | Film No.: 20958027
SIC: 2834 Pharmaceutical Preparations